Maternal rubella infection, especially during the first trimester, can cause congenital rubella syndrome (CRS) in the fetus and result in multiple serious birth defects, including ophthalmologic, auditory, neurologic, and cardiac defects. Maternal rubella infection is often a mild illness, typically characterized by rash, lymphadenopathy, and fever, although up to 50% of infected people are asymptomatic [1] . Attributable to a successful vaccination program, rubella was declared eliminated in the United States in 2004 [2] . However, transmission continues in countries without rubella-elimination programs, which leads to infants with CRS being born to women in the United States who acquired infection internationally; these cases of rubella are considered imported. During 2004-2012, 6 CRS cases were reported to the Centers for Disease Control and Prevention (CDC); 5 were import associated, and the source for 1 was unknown [3] .
To prevent maternal rubella infection and subsequent CRS, the American Congress of Obstetricians and Gynecologists recommends that girls and women of reproductive age be evaluated for rubella immunity during a preconception visit and that those who are susceptible be vaccinated before pregnancy [4] . However, because women often do not receive preconception care or screening [5] , routine prenatal panels include testing for the presence of rubella immunoglobulin G (IgG) antibodies to determine immunity. Although rubella-specific IgG antibodies during pregnancy usually reflect pregravid immunity in the majority of US obstetric patients, an IgG titer cannot distinguish between immunity from past infection, vaccination, and recent infection. Rubella immunoglobulin M (IgM) antibody testing can be used to diagnose acute infection but is not recommended for routine prenatal screening because of false-positivity concerns.
Infection control and elimination can be challenging, because infants with CRS can shed infectious virus in their urine, blood, and respiratory secretions for >1 year [1] . Isolation precautions, including contact precautions, should be used for infants with CRS. Certain sources also recommend droplet precautions [6] . Delay in diagnosis and infection control measures can lead to secondary transmission. Infants are considered to be infectious until 2 consecutive negative rubella test (viral culture or reverse transcription-polymerase chain reaction [RT-PCR]) results are found in clinical specimens obtained 1 month apart after the infant has reached >3 months of age [1] . The incubation period for postnatally acquired rubella is 14 to 21 days [1] . Here, we describe 2 infants with CRS identified in New York State (NYS) between 2013 and 2015.
CASE REPORTS

Case 1
In 2013, a male infant was born at 33 weeks' gestation in NYS hospital A. The infant had multiple purpuric lesions, intrauterine growth retardation, bilateral retinal hemorrhages, thrombocytopenia, neutropenia, hypocalcemia, anemia, intracranial calcifications, bilateral hearing deficits, fraying of his femurs, slight jaundice, elevated liver enzyme levels, patent ductus arteriosus, patent foramen ovale, and moderate peripheral pulmonary artery stenosis. The infant was treated with ampicillin and gentamicin for possible sepsis. Congenital cytomegalovirus infection was ruled out by PCR testing on the fourth day of life (DOL).
Serum samples collected on DOL 11 and 13 contained rubella-specific IgG and IgM antibodies as tested and determined by the CDC Rubella Virus Laboratory and NYS Department of Health Wadsworth Center Diagnostic Immunology Laboratory. The throat and nasal specimens collected on DOL 13 contained rubella virus as detected by real-time RT-PCR (rRT-PCR) at the Wadsworth Center Vaccine Preventable Diseases Reference Laboratory. Sequencing, performed in the Applied Genomics and Technology Core at Wadsworth Center, followed by phylogenetic analysis of the genomic E1 fragment, identified the virus as genotype 1E. Testing at the CDC revealed high IgG avidity, indicating that rubella infection had occurred >3 months before testing, during gestation [7] . At the age of 7.5 months, the infant had developmental delay, profound bilateral hearing loss, and poor weight gain.
The mother, aged in her early 20s, had visited Yemen during the first 25 weeks of pregnancy. She reported a fever and cough throughout her pregnancy but no rash. The results of maternal rubella IgG antibody testing performed in the United States at 28.5 weeks' gestation as part of routine prenatal screening were positive. Documentation from a 2005 immigration medical examination reported that she had received 2 doses of measles, mumps, and rubella (MMR) vaccine; however, the vaccine would have been administered in Yemen, where rubella vaccine was not included in the national vaccination schedule at that time [8] ; therefore, the accuracy of the mother's vaccination history is uncertain.
After the CRS diagnosis was made, ~2 weeks after the child's birth, the hospital and public health authorities initiated control measures. Hospital A had placed the infant in contact isolation on DOL 5. Droplet precautions were added on DOL 13. Fourteen potentially exposed persons were identified, including 8 infant patients and 6 close family members. Eleven of the 14 persons had evidence of immunity to rubella, 1 on the basis of documentation of 2 MMR vaccinations, 2 on the basis of rubella-specific IgG antibodies, and 8 (all of the exposed newborns) on the basis of maternal rubella-specific IgG antibodies. The remaining 3 persons had the same rubella vaccination documentation as the mother, indicating MMR doses administered in Yemen. They were offered MMR vaccination but did not present to the vaccination clinic.
The infant was discharged after 6 weeks, and he and his contacts were followed by public health authorities. Nasopharyngeal specimens were tested approximately every 3 months until virus was no longer detected by rRT-PCR. The second of 2 consecutive PCR-negative specimens was collected on DOL 221 (165 days after the last specimen that tested positive). No secondary cases were identified.
Case 2
In 2015, a dichorionic diamniotic twin girl with intrauterine growth retardation was born in NYS hospital B at 35 weeks' gestation. At delivery, the infant developed respiratory distress and remained intubated for 3 days. Surfactant was administered, and ampicillin and gentamicin were started to treat possible sepsis. The other twin was stillborn. No diagnostic evaluation or autopsy was performed.
The surviving infant had periventricular leukomalacia, tricuspid and mitral valve regurgitation, patent foramen ovale, atrial septal defect, patent ductus arteriosus, clitoromegaly, and cleft lip and palate. Bilateral congenital posterior cataracts were detected on DOL 33, although results of a red-reflex examination at birth were normal. Hearing loss was diagnosed on approximately DOL 56. Karyotype assays did not identify any chromosomal abnormalities. Rubella was reportedly considered lower on the differential because the mother had a positive prenatal rubella IgG test and was considered to be immune. On DOL 54, the infant was transferred to hospital C for further management. Rubella was suspected, and serum collected on DOL 57 contained rubella IgM antibodies. The Wadsworth Center Vaccine Preventable Diseases Reference Laboratory detected rubella virus in her urine and nasopharyngeal specimens by using rRT-PCR and identified the genotype 2B by sequencing and phylogenetic analysis of the E1 genomic fragment.
The mother, aged approximately 20 years, spent the first 20 weeks of her pregnancy in Yemen. She denied rubella symptoms while pregnant and had tested rubella IgG positive during her third trimester as part of routine prenatal screening in the United States. Her vaccination history was unknown. After the diagnosis of CRS was made on DOL 57, hospital B, hospital C, and public health authorities initiated control measures. At hospital B, the infant had been in an enclosed isolette ≥3 feet from other isolettes, the minimum distance advised for contact and droplet precautions [9] . A total of 79 exposed contacts were identified, all of whom were healthcare workers and had evidence of rubella immunity based on preexposure rubella-specific IgG antibodies. At hospital C, the infant was in an open bassinet for 3 days before being placed on contact and droplet precautions. A total of 57 exposed contacts were identified, including 47 healthcare workers, 5 visitors, and 5 infant patients, all of whom had evidence of immunity to rubella based on their birth before 1957, employee health records, 2 MMR vaccinations, or, for the newborns, maternal rubella-specific IgG antibodies. The infant was discharged to a long-term-care pediatric hospital on DOL 98. Public health authorities ensured that potential close contacts and caregivers were educated about precautions to prevent rubella transmission. The infant and her contacts were monitored by public health authorities until she was determined on DOL 219 to be noninfectious, after 2 consecutive negative rRT-PCR assay results obtained 1 month apart (73 days after the last specimen that tested positive). No secondary cases of rubella were identified.
DISCUSSION
In 2015, the World Health Organization's Americas region became the first in the world to be declared free of endemic transmission of rubella [8] . The southeast Asia, European, and Western Pacific regions have plans for rubella elimination or control before or by 2020 [10] . Although substantial progress has been made toward its elimination, rubella is still endemic in multiple regions of the world. As of December 2014, a total of 54 (28%) countries, including countries in Africa, the eastern Mediterranean, southeast Asia, and Western Pacific regions, had not introduced a rubella-containing vaccine [8] . Girls and women born in these countries might not have received rubella vaccination and might be susceptible to infection during pregnancy, and their immunization records might be inaccurate. During 1998-2004, of 28 CRS cases reported in the United States, 26 (93%) of the mothers were foreign born [11] . Approximately one-third of NYS births are to foreign-born women [12] .
Positive rubella IgG titers might provide false reassurance when found as part of a routine prenatal panel in pregnant women who were in a country where rubella is endemic, particularly among foreign-born women and women without clear documentation of rubella immunity before travel. Similar to the CRS cases we have presented here, others cases of positive rubella IgG titers during pregnancy that misled providers and resulted in delayed consideration of a CRS diagnosis have been reported [3, 13] . In our cases, delayed diagnosis and lack of isolation precautions immediately after birth resulted in numerous exposures and a substantial public health response. Early consideration of CRS and isolation precautions can prevent secondary transmission and an extensive public health investigation.
CONCLUSIONS
Clinicians should consider CRS in infants with compatible signs and whose mother's vaccination status is unknown, especially if the mother was foreign born. IgG rubella antibodies found on prenatal panels do not rule out CRS, and isolation precautions and vaccination of susceptible contacts should be considered. 
